CoChat

Suramin Antiviral Therapy in the Acquired Immunodeficiency Syndrome: Clinical, Immunologic, and Virologic Results

LEVINE, ALEXANDRA M., GILL, PARKASH S., COHEN, JORDAN, HAWKINS, JEAN G., FORMENTI, SILVIA C., AGUILAR, SCOTT, MEYER, PAUL R., KRAILO, MARK, PARKER, JOHN, RASHEED, SURAIYA · 1986 · Annals of Internal Medicine
Cited by 104

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

The human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) requires reverse transcriptase for viral replication. We treated 12 patients who had acquired immunodeficiency syndrome and active HTLV-III/LAV viremia with suramin, a potent competitive inhibitor of reverse transcriptase, in six weekly induction doses of 1 g, followed by weekly maintenance doses of 500 mg. Three of eleven evaluable patients had complete inhibition of viral reverse transcriptase levels, lasting at least 18 weeks in each. Two additional patients had marked reduction in reverse transcriptase activity. Nadir serum suramin levels at the end of the induction phase correlated with the level of reverse transcriptase reduction. Toxicity included hepatic transaminase elevation, fever, malaise, rash, proteinuria, paresthesias, reversible neutropenia, and adrenal insufficiency. Objective clinical improvement was documented in 1 patient, but no patient had improvement in immune function and 7 patients had recurrent opportunistic infections. Although suramin may suppress HTLV-III/LAV viremia, its significant toxicity and lack of effect on immune variables indicate that alternative therapy will be required.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/0003-4819-105-1-32

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 104

Metadata

Authors
LEVINE, A. M., GILL, P. S., COHEN, J., HAWKINS, J. G., FORMENTI, S. C., AGUILAR, S., MEYER, P. R., KRAILO, M., PARKER, J., & RASHEED, S.
Venue
Annals of Internal Medicine
Published
1986-07-01
Volume
105
Issue
1
Pages
32-37
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2050470509
Cited by
104
References
1
FWCI
10.71
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Suramin Antiviral Therapy in the Acquired Immunodeficiency Syndrome: Clinical, Immunologic, and Virologic Results. https://app.cochat.ai/papers/10.7326/0003-4819-105-1-32
The paper
LEVINE, A. M., GILL, P. S., COHEN, J., HAWKINS, J. G., FORMENTI, S. C., AGUILAR, S., MEYER, P. R., KRAILO, M., PARKER, J., & RASHEED, S. (1986). Suramin Antiviral Therapy in the Acquired Immunodeficiency Syndrome: Clinical, Immunologic, and Virologic Results. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-105-1-32

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.